IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 214 filers reported holding IMMUNOGEN INC in Q4 2020. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $11,094,968 | -16.0% | 699,116 | -0.2% | 0.01% | -10.0% |
| Q2 2023 | $13,215,097 | +13665.7% | 700,323 | +5300.0% | 0.01% | – |
| Q4 2021 | $96,000 | +29.7% | 12,969 | 0.0% | 0.00% | – |
| Q3 2021 | $74,000 | -25.3% | 12,969 | -13.4% | 0.00% | – |
| Q2 2021 | $99,000 | -41.8% | 14,982 | -28.5% | 0.00% | – |
| Q1 2021 | $170,000 | +146.4% | 20,944 | +96.8% | 0.00% | – |
| Q4 2020 | $69,000 | -95.5% | 10,643 | -90.6% | 0.00% | -100.0% |
| Q4 2015 | $1,541,000 | +40.9% | 113,550 | -0.3% | 0.00% | +100.0% |
| Q3 2015 | $1,094,000 | -27.4% | 113,927 | +8.7% | 0.00% | -50.0% |
| Q2 2015 | $1,507,000 | +77.7% | 104,829 | +30.9% | 0.00% | +100.0% |
| Q3 2014 | $848,000 | -5.8% | 80,058 | +5.4% | 0.00% | 0.0% |
| Q2 2014 | $900,000 | +14.4% | 75,984 | +44.2% | 0.00% | 0.0% |
| Q1 2014 | $787,000 | -5.6% | 52,680 | -7.4% | 0.00% | 0.0% |
| Q4 2013 | $834,000 | -13.6% | 56,880 | +0.3% | 0.00% | 0.0% |
| Q3 2013 | $965,000 | +9.4% | 56,710 | +6.7% | 0.00% | 0.0% |
| Q2 2013 | $882,000 | – | 53,160 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 10,477,879 | $37,720,000 | 0.69% |
| QVT Financial LP | 1,375,900 | $4,953,000 | 0.60% |
| RA Capital Management | 7,040,485 | $25,346,000 | 0.46% |
| Birchview Capital, LP | 380,000 | $1,368,000 | 0.46% |
| XTX MARKETS LLC | 18,861 | $68,000 | 0.33% |
| Fernwood Investment Management, LLC | 154,340 | $556,000 | 0.26% |
| TWIN FOCUS CAPITAL PARTNERS, LLC | 104,068 | $375,000 | 0.14% |
| Virtus ETF Advisers LLC | 70,213 | $253,000 | 0.13% |
| KENNEDY CAPITAL MANAGEMENT LLC | 1,251,458 | $4,505,000 | 0.13% |
| Assenagon Asset Management S.A. | 4,987,334 | $17,954,000 | 0.10% |